Advertisement

Index by author

August 01, 1989; Volume 250,Issue 2

  1. Acad, B A

    1. Regional O2 consumption and coronary flow during beta adrenoceptor stimulation in reperfused canine myocardium.
      B A Acad and H R Weiss
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 611-616;

  2. Amrick, C L

    1. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;

  3. Anderson, D

    1. Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor.
      M McKinney, D Anderson, C Forray and E E el-Fakahany
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 565-572;

  4. Antonelli, T

    1. Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;

  5. Baarnhielm, C

    1. Contribution of the intestine to the first-pass metabolism of felodipine in the rat.
      S X Wang, T A Sutfin, C Bäärnhielm and C G Regårdh
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 632-636;

  6. Balduini, W

    1. Effects of ethanol on muscarinic receptor-stimulated phosphoinositide metabolism during brain development.
      W Balduini and L G Costa
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 541-547;

  7. Barnett, A

    1. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
      E J Sybertz, P J Chiu, S Vemulapalli, B Pitts, C J Foster, R W Watkins, A Barnett and M F Haslanger
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 624-631;

  8. Beani, L

    1. Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
      L Beani, S Tanganelli, T Antonelli, M Simonato, P Spalluto, C Tomasini and C Bianchi
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 682-687;

  9. Bennett, D A

    1. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;

  10. Bernard, P S

    1. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
      D A Bennett, P S Bernard, C L Amrick, D E Wilson, J M Liebman and A J Hutchison
      Journal of Pharmacology and Experimental Therapeutics August 1989, 250 (2) 454-460;
« Previous (Pages : 1 2 3 4 5 6 ... 17) Next »
Back to top

In this issue

Advertisement